Contrast-enhanced pelvic magnetic resonance imaging (MRI) for the prediction of treatment response in mucinous rectal cancer
Maria El Homsi(Memorial Sloan Kettering Cancer Center), Yousef Mazaheri(Memorial Sloan Kettering Cancer Center), Natalie Gangai(Memorial Sloan Kettering Cancer Center), Marc J. Gollub(Memorial Sloan Kettering Cancer Center), Onur Yıldırım(Memorial Sloan Kettering Cancer Center), Jinru Shia(Memorial Sloan Kettering Cancer Center)
Cited by 4
Related Papers
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
|JAMA Oncology|2018|661
Preoperative Treatment of Locally Advanced Rectal Cancer
|New England Journal of Medicine|2023|440
Long-term Oncologic Outcome Following Preoperative Combined Modality Therapy and Total Mesorectal Excision of Locally Advanced Rectal Cancer
|Annals of Surgery|2005|388
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper
|Nature Reviews Clinical Oncology|2020|365